ProfileGDS4718 / 226243_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 91% 79% 93% 91% 93% 91% 92% 92% 92% 93% 92% 91% 89% 91% 93% 93% 90% 92% 90% 93% 93% 93% 94% 92% 92% 93% 91% 89% 89% 91% 92% 89% 91% 90% 94% 89% 92% 91% 79% 90% 90% 86% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.7041692
GSM549102patient 115, normal, homogenized [OPG study]9.4444291
GSM549104patient 119, normal, homogenized [OPG study]7.8288679
GSM549108patient 138, normal, homogenized [OPG study]9.6858193
GSM549119patient 077, normal, homogenized [OPG study]9.4456991
GSM549133patient 032, cancer, homogenized [OPG study]9.791993
GSM549139patient 042, cancer, homogenized [OPG study]9.3773291
GSM549099patient 107, normal, homogenized [OPG study]9.5292392
GSM549109patient 139, normal, homogenized [OPG study]9.6419392
GSM549110patient 046, normal, homogenized [OPG study]9.7334792
GSM549114patient 063, normal, homogenized [OPG study]9.9056593
GSM549122patient 082, normal, homogenized [OPG study]9.6581892
GSM549134patient 033, cancer, homogenized [OPG study]9.3642691
GSM549136patient 036, cancer, homogenized [OPG study]9.1032289
GSM549140patient 044, cancer, homogenized [OPG study]9.3973691
GSM549111patient 047, normal, homogenized [OPG study]9.8324293
GSM549113patient 057, normal, homogenized [OPG study]9.9385193
GSM549132patient 031, cancer, homogenized [OPG study]9.1546890
GSM549137patient 038, cancer, homogenized [OPG study]9.5522992
GSM549142patient 047, cancer, homogenized [OPG study]8.720190
GSM549100patient 110, normal, homogenized [OPG study]9.8612793
GSM549107patient 135, normal, homogenized [OPG study]9.7689293
GSM549115patient 068, normal, homogenized [OPG study]9.9721593
GSM549116patient 072, normal, homogenized [OPG study]10.027894
GSM549120patient 078, normal, homogenized [OPG study]9.606692
GSM549131patient 030, cancer, homogenized [OPG study]9.5681192
GSM549118patient 074, normal, homogenized [OPG study]9.780593
GSM549129patient 027, cancer, homogenized [OPG study]9.2443691
GSM549123patient 088, normal, homogenized [OPG study]9.0585189
GSM549124patient 006, cancer, homogenized [OPG study]8.9562789
GSM549126patient 015, cancer, homogenized [OPG study]9.3603191
GSM549128patient 025, cancer, homogenized [OPG study]9.597692
GSM549103patient 117, normal, homogenized [OPG study]8.8662889
GSM549117patient 073, normal, homogenized [OPG study]9.6016391
GSM549138patient 041, cancer, homogenized [OPG study]9.2751590
GSM549141patient 045, cancer, homogenized [OPG study]10.076894
GSM549130patient 028, cancer, homogenized [OPG study]8.9568189
GSM549101patient 111, normal, homogenized [OPG study]9.5812692
GSM549105patient 128, normal, homogenized [OPG study]9.3877491
GSM549106patient 134, normal, homogenized [OPG study]7.8856379
GSM549112patient 048, normal, homogenized [OPG study]9.3574690
GSM549125patient 011, cancer, homogenized [OPG study]9.1987690
GSM549127patient 024, cancer, homogenized [OPG study]8.5962486
GSM549135patient 035, cancer, homogenized [OPG study]10.029194